Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Roger M. Perlmutter
Age : 67
Public asset : 20,143,764 USD
Linked companies : NGM Biopharmaceuticals, Inc.
Summary 
Roger M. Perlmutter is a businessperson who has been at the head of 6 different companies and is Chairman & Chief Executive Officer at Eikon Therapeutics, Inc. Dr. Perlmutter is also on the board of NGM Biopharmaceuticals, Inc., Institute for Systems Biology (former Chairman), Exonics Therapeutics, Inc. and Insitro, Inc. and Chairman of Reed College and Science Partner at The Column Group LLC.

In the past he held the position of Executive VP & Head-Research & Development at Amgen, Inc. and President & Director at Alantos Pharmaceuticals Holding, Inc. (a subsidiary of Amgen, Inc.), EVP-Worldwide Basic & Preclinical Research at Merck & Co., Inc. and Non-Executive Director at Merck Research Laboratories Massachusetts LLC (a subsidiary of Merck & Co., Inc.), Executive Vice President of Merck & Co., Inc. and Non-Executive Director at Merck Research Laboratories Massachusetts LLC (a subsidiary of Merck & Co., Inc.), President of The American Association of Immunologists and Chairman-Immunology Department & Professor at the University of Washington.

Roger M. Perlmutter received an undergraduate degree from Reed College and a doctorate from Washington University in St. Louis.


Current positions of Roger M. Perlmutter 
NameTitle Since
NGM Biopharmaceuticals, Inc.
(Biotechnology & Medical Research)
Director 2021
Eikon Therapeutics, Inc. Chairman & Chief Executive Officer -
Reed College Chairman 2012
Institute for Systems Biology Director 2013
Exonics Therapeutics, Inc. Director 2018
Insitro, Inc. Independent Director 2020
The Column Group LLC Science Partner -


Holdings of Roger M. Perlmutter 
NameEquities%Valuation
Merck & Co., Inc. (MRK)
(Pharmaceuticals)
264,0420.010%20,143,764 USD


Roger M. Perlmutter: Personal Network 
Most Read News 
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
03:58pWILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Roger M. Perlmutter : Connections